Clinical Trial Site

Ehime

0 studies enrolling now · 1 studies all time

What they study most

Amyloidosis

Studies at this site

• The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran) — Completed